# Post-Market Bioequivalence of Generic Drug Product

Canonical: https://abierto.us/opportunities/75f40124r00023

- Solicitation number: 75F40124R00023
- Notice type: Solicitation
- Status: Closed. Deadline was January 24, 2024 at 10:00 AM EST
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Center for Drug Evaluation and Research (75DKKN)
- NAICS: 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Product or service code: B529 Scientific Data Studies
- Set-aside: 8(a) set-aside
- First posted: January 3, 2024
- Last posted: January 3, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/dd88a10420b4470e9f1af897fe438c04/view

## Description

Post-Market Bioequivalence of Generic Drug Product 01/03/2024- Amendment to provide the government's response to quesions and to provide a new proposal due date. Proposals are due 10AM EST 01/24/2024

## Publications

- January 3, 2024: Solicitation, due January 12, 2024 at 10:00 AM EST. Notice a061632886ee4a9db8436d9ca0b64491. https://sam.gov/workspace/contract/opp/a061632886ee4a9db8436d9ca0b64491/view
- January 3, 2024: Solicitation, due January 24, 2024 at 10:00 AM EST. Notice dd88a10420b4470e9f1af897fe438c04. https://sam.gov/workspace/contract/opp/dd88a10420b4470e9f1af897fe438c04/view

## Points of contact

- Telisha WIlson, telisha.wilson@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75f40124r00023.